rHEALTH Technology Issued New Patent For Optical Block

CAMBRIDGE, Mass., December 5, 2017 - rHEALTH LLC announces the issuance of a new patent in the United States for innovations in optical systems engineering filed by DNA Medicine Institute, DMI. This innovation underscores the portability as well as unique measurement capabilities of the rHEALTH digital diagnostic platform, which represents the miniaturization and automation of traditional laboratory testing technologies as a point-of-care solution.

The U.S. Patent and Trademark Office has granted the patent number 9,835,542, “Optical Block,” for a highly portable and compact, integrated diagnostic system that is designed to measure cells and particles. The unique combination of lasers, detectors, flow channel, lenses, and other electronics within the optical system work to enable precise biomedical measurements. “We are pleased to see this latest patent issuance, which covers one of the core aspects of our diagnostic technology,” said Dr. Eugene Y. Chan, Founder and CEO. “The fundamental aspect of this patent enables our technology to make accurate, precise, and quantitative values possible at point-of-care.”

This new patent expands the companies’ intellectual property portfolio demonstrating DMI and rHEALTH’s ongoing commitment to better care through innovation in portable diagnostics and monitoring technologies.

About rHEALTH

rHEALTH is an innovative digital health solutions company focused on creating integrated technologies that fundamentally change how we care for our health. rHEALTH’s innovations consists of the rHEALTH diagnostic platform, which enables diverse laboratory test classes in a single small volume blood sample intended as a point-of-care solution, the SKYE Sensor, a wireless wearable providing comprehensive real-time vitals monitoring and CHAS, a user-friendly mobile application. For more information, visit www.rhealth.com.

About DNA Medicine Institute

DNA Medicine Institute (DMI) is a biomedical incubator focused on advancing patient care, alleviating human suffering, and treating disease through innovation. Its work is supported by NASA, National Institutes of Health, and the Bill & Melinda Gates Foundation. DMI leverages substantial expertise in interdisciplinary science and engineering to solve challenging problems. For more information, visit www.dnamedinstitute.com.

Media Contact
Lillian Li

(617) 913-7630

pr@rhealth.com